Lv4
640 积分 2023-11-10 加入
Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis
1个月前
已完结
Movement disorders: advances on many fronts
3个月前
已完结
Huntington disease
3个月前
已完结
Regulatory T cells shield muscle mitochondria from interferon-γ–mediated damage to promote the beneficial effects of exercise
4个月前
已完结
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)
4个月前
已完结
The characteristic of nonmotor symptoms with different phenotypes and onsets in multiple system atrophy patients
6个月前
已完结
Multiple system atrophy: insights into a rare and debilitating movement disorder
6个月前
已完结
Recent Advances in Clinical Trials in Multiple System Atrophy
6个月前
已完结
The effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclerosis
6个月前
已完结
Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis
6个月前
已完结
皖公网安备34019202002308
